Regeneron Pharmaceuticals (REGN) Revenue (QoQ) (2009 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.18% |
| Dec 31, 2025 | 3.46% |
| Sep 30, 2025 | 2.14% |
| Jun 30, 2025 | 21.36% |
| Mar 31, 2025 | -20.07% |
| Dec 31, 2024 | 1.84% |
| Sep 30, 2024 | 4.89% |
| Jun 30, 2024 | 12.79% |
| Mar 31, 2024 | -8.42% |
| Dec 31, 2023 | 2.13% |
| Sep 30, 2023 | 6.48% |
| Jun 30, 2023 | -0.13% |
| Mar 31, 2023 | 3,062.10% |
| Dec 31, 2022 | -96.59% |
| Sep 30, 2022 | 2.76% |
| Jun 30, 2022 | 5,614.40% |
| Mar 31, 2022 | -98.99% |
| Dec 31, 2021 | 43.41% |
| Sep 30, 2021 | -32.81% |
| Jun 30, 2021 | 103.21% |
| Mar 31, 2021 | 4.37% |
| Dec 31, 2020 | 5.62% |
| Sep 30, 2020 | 17.52% |
| Jun 30, 2020 | 6.77% |
| Mar 31, 2020 | -1.89% |
| Dec 31, 2019 | 6.87% |
| Sep 30, 2019 | 10.51% |
| Jun 30, 2019 | 14.95% |
| Mar 31, 2019 | -28.80% |
| Dec 31, 2018 | 15.89% |
| Sep 30, 2018 | 3.45% |
| Jun 30, 2018 | 6.38% |
| Mar 31, 2018 | -4.48% |
| Dec 31, 2017 | 5.44% |
| Sep 30, 2017 | 2.08% |
| Jun 30, 2017 | 11.46% |
| Mar 31, 2017 | 7.51% |
| Dec 31, 2016 | 0.55% |
| Sep 30, 2016 | 0.62% |
| Jun 30, 2016 | 0.98% |
| Mar 31, 2016 | 9.36% |
| Dec 31, 2015 | -3.46% |
| Sep 30, 2015 | 13.90% |
| Jun 30, 2015 | 14.83% |
| Mar 31, 2015 | 8.39% |
| Dec 31, 2014 | 10.55% |
| Sep 30, 2014 | 9.03% |
| Jun 30, 2014 | 6.39% |
| Mar 31, 2014 | 2.51% |
| Dec 31, 2013 | 2.24% |
| Sep 30, 2013 | 30.46% |
| Jun 30, 2013 | 4.09% |
| Mar 31, 2013 | 6.04% |
| Dec 31, 2012 | -3.06% |
| Sep 30, 2012 | 40.50% |
| Jun 30, 2012 | 31.33% |
| Mar 31, 2012 | 88.48% |
| Dec 31, 2011 | 19.59% |
| Sep 30, 2011 | -4.62% |
| Jun 30, 2011 | -3.92% |
| Mar 31, 2011 | 960.46% |
| Dec 31, 2010 | -364.18% |
| Sep 30, 2010 | -95.74% |
| Jun 30, 2010 | 6,044.54% |
| Mar 31, 2010 | -85.64% |
| Dec 31, 2009 | -88.82% |
| Sep 30, 2009 | 2,510.11% |